DEXA Body Composition: Evidence-Based Ways to Improve Your Numbers

What Does a DEXA Body Composition Scan Actually Measure?

A DEXA scan uses two low-energy X-ray beams to distinguish fat tissue, lean soft tissue, and bone in each body region. The output is not a single number. It is a multi-compartment report covering total body fat percentage, regional fat distribution (android versus gynoid), visceral adipose tissue (VAT) area in cm², total lean mass in kilograms, appendicular lean mass index (ALMI), and bone mineral density (BMD) in g/cm².

The Three Numbers That Matter Most Clinically

Body fat percentage is the most commonly referenced figure, but it can mislead if read in isolation. Two people at 30% body fat may have entirely different metabolic risk profiles depending on where that fat sits.

Visceral adipose tissue (VAT) is the stronger metabolic predictor. A 2019 analysis published in the Journal of the American Heart Association found that VAT area above 100 cm² was independently associated with increased cardiometabolic risk even in individuals with a normal BMI [1]. Subcutaneous fat carries far less risk per unit volume.

Appendicular lean mass index (total arm plus leg lean mass divided by height in meters squared) predicts functional capacity, insulin sensitivity, and all-cause mortality better than total lean mass alone. The Foundation for the National Institutes of Health Sarcopenia Project set a low ALMI threshold of <7.0 kg/m² in men and <5.4 kg/m² in women [2].

How Precise Is the Test?

DEXA has a least significant change (LSC) of approximately 1 to 2% for body fat and roughly 0.5 to 1.0 kg for lean mass when the same machine and technician are used. Hydration status, time of day, and recent exercise all introduce noise. Schedule repeat scans under identical conditions: same machine, morning, fasted, no exercise the prior day.

Normal DEXA Body Composition Ranges

Interpreting your scan requires age- and sex-specific reference data, not a single population average. The American Council on Exercise (ACE) categories are the most commonly applied clinical reference, though the Endocrine Society and AACE use slightly different cut-points in their obesity guidelines.

Body Fat Percentage by Category

| Category | Men | Women | |---|---|---| | Essential fat | 2 to 5% | 10 to 13% | | Athletic | 6 to 13% | 14 to 20% | | Fitness | 14 to 17% | 21 to 24% | | Acceptable | 18 to 24% | 25 to 31% | | Obese | >25% | >32% |

The 2023 American Association of Clinical Endocrinology (AACE) obesity guidelines note that "adiposity-based chronic disease" should be diagnosed by body fat percentage and VAT distribution rather than BMI alone, because BMI misclassifies up to 30% of individuals [3].

What a High Body Fat Percentage Means

A DEXA fat percentage above the obese threshold, or a VAT area above 160 cm², is associated with insulin resistance, dyslipidemia, non-alcoholic fatty liver disease, and increased cardiovascular event risk. These are not cosmetic thresholds. A cross-sectional analysis in Diabetes Care (N=6,230) found that each 10 cm² increment in VAT was associated with a 4% increase in type 2 diabetes incidence over 5 years, independent of subcutaneous fat [4].

What a Low Lean Mass Reading Means

Low ALMI (below the FNIH thresholds above) meets criteria for sarcopenia when accompanied by low grip strength or slow gait speed. The European Working Group on Sarcopenia in Older People (EWGSOP2) 2018 consensus defines probable sarcopenia by low muscle strength alone and confirmed sarcopenia by low muscle quantity on imaging [5]. In younger adults, a low lean mass reading is more often a training and protein adequacy problem than a disease state, but it still warrants action because muscle mass is the primary site of glucose disposal.

How to Lower Body Fat on DEXA: What the Trials Show

Fat loss on DEXA requires a sustained caloric deficit. The debate is not whether a deficit works. It is which deficit size, combined with which dietary pattern, produces the best fat-to-lean mass ratio of weight lost.

Caloric Deficit Magnitude

A 500 kcal per day deficit produces approximately 0.45 kg of weight loss per week in metabolic ward conditions, but free-living averages run closer to 0.3 kg per week due to adherence drift. A 2020 meta-analysis in Obesity Reviews (35 RCTs, N=3,521) found that deficits above 750 kcal per day did not produce proportionally faster fat loss and significantly increased lean mass losses compared to 500 kcal deficits [6]. Aggressive restriction accelerates catabolism.

Dietary Pattern: Protein First

Protein intake is the single dietary variable most consistently shown to preserve lean mass during a deficit. A 2017 systematic review in the British Journal of Sports Medicine (49 RCTs, N=1,817) found that protein intakes above 1.62 g/kg/day maximized lean mass retention, with no additional benefit detected above 2.2 g/kg/day [7]. Practical target: 1.6 to 2.0 g per kilogram of target body weight per day, distributed across at least four meals.

The source of protein matters less than total daily intake for most adults. Whey, casein, soy, and pea protein all perform comparably in head-to-head lean mass retention trials when isonitrogenous amounts are compared.

Resistance Training During a Deficit

Resistance training during a caloric deficit shifts the fat-to-lean mass ratio of weight lost dramatically. A 2021 RCT in the Journal of Strength and Conditioning Research (N=88, 16 weeks, 500 kcal deficit) found that the group combining resistance training with a high-protein diet lost 7.2 kg of fat and gained 1.1 kg of lean mass, whereas the diet-only group lost 6.9 kg of fat but also lost 2.3 kg of lean mass [8]. The scale weight was nearly identical. The DEXA results were not.

Three to four sessions per week of progressive resistance training, targeting all major muscle groups with a load of 60 to 85% of one-repetition maximum, is the evidence-supported minimum during active fat loss phases.

How to Increase Lean Mass on DEXA

Building lean mass (muscle hypertrophy plus connective tissue remodeling) requires a consistent mechanical stimulus, sufficient protein, and either a caloric surplus or a precise maintenance intake. Simultaneous fat loss and muscle gain, sometimes called body recomposition, is achievable but slower than prioritizing one goal at a time.

Progressive Overload Specifics

The American College of Sports Medicine (ACSM) position stand on resistance training recommends 3 to 6 sets per muscle group per session, 8 to 12 repetitions at 67 to 85% of 1RM, with 60 to 120 seconds rest between sets for hypertrophy [9]. Volume, not intensity alone, is the primary driver of hypertrophy above a minimum effective dose threshold.

Training frequency of 2 times per week per muscle group is sufficient to produce 80 to 90% of the hypertrophy response achievable with higher frequencies, based on a 2016 meta-analysis in the Journal of Strength and Conditioning Research (N=398 subjects across 10 RCTs) [10].

Protein Timing

Post-exercise protein synthesis is elevated for up to 24 to 48 hours after a resistance session, not just the 30-minute "anabolic window" that fitness culture has long promoted. A 2013 meta-analysis in the Journal of the International Society of Sports Nutrition found no statistically significant effect of protein timing within 1 hour of exercise when total daily protein was matched [11]. Hit the daily protein target first. Timing is a secondary optimization.

Sleep, Cortisol, and Lean Mass

Chronic sleep restriction (<6 hours per night) elevates cortisol and suppresses IGF-1, producing a hormonal environment that favors catabolism. A controlled study published in the Annals of Internal Medicine (N=10, crossover design) found that cutting sleep from 8.5 to 5.5 hours reduced the proportion of weight lost as fat from 55% to 25%, while the lean mass loss proportion roughly doubled [12]. Lean mass targets are harder to hit on short sleep.

GLP-1 and GIP/GLP-1 Agonists: DEXA Implications for Patients on Semaglutide or Tirzepatide

Patients using GLP-1 receptor agonists for weight management need specific DEXA guidance because these medications produce rapid, significant weight loss that carries a lean mass penalty if not actively countered.

The Lean Mass Loss Problem

In the STEP-1 trial (N=1,961, 68 weeks), semaglutide 2.4 mg subcutaneous weekly produced 14.9% mean total body weight loss versus 2.4% with placebo [13]. A DEXA substudy of STEP-1 showed that approximately 39% of the total weight lost was lean mass, which is higher than the 25 to 30% lean mass loss typically seen with lifestyle-only interventions.

The SURMOUNT-1 trial (N=2,539) with tirzepatide 15 mg showed 20.9% mean body weight reduction at 72 weeks [14]. Lean mass data from the body composition sub-cohort suggested a similar 35 to 40% lean mass loss ratio without a concurrent resistance program.

Protecting Lean Mass on GLP-1 Therapy

The following three-component protocol represents the HealthRX clinical framework for lean mass preservation during GLP-1 therapy, developed from the trial data above and the Endocrine Society's 2023 obesity pharmacotherapy position statement:

1. Resistance training: Minimum 3 sessions per week, full-body or upper/lower split, progressive overload. This is non-negotiable, not optional.
2. Protein target: 1.8 to 2.2 g/kg of goal body weight per day. Patients on GLP-1 therapy frequently under-eat protein due to appetite suppression. Liquid or semi-solid protein sources (Greek yogurt, protein shakes, cottage cheese) help meet targets when solid food intake feels difficult.
3. DEXA retest at 12 to 16 weeks: If lean mass has dropped more than 1.5 kg on DEXA, the clinical team should evaluate whether a dose reduction, a diet break, or creatine supplementation (3 to 5 g per day, which has a modest but consistent lean mass preservation effect in multiple meta-analyses) is appropriate.

The Endocrine Society's 2023 clinical practice guideline on obesity management states: "Weight loss interventions should be accompanied by exercise and adequate protein intake to minimize the loss of lean body mass, which has long-term implications for metabolic health and functional capacity." [15]

Specific Interventions with DEXA-Measured Evidence

Several interventions have been tested with DEXA as the primary outcome measure, which is a more rigorous standard than scale weight or BMI.

Creatine Monohydrate

A 2017 meta-analysis in the Journal of Strength and Conditioning Research (22 RCTs, N=721) found that creatine monohydrate supplementation combined with resistance training produced a mean additional lean mass gain of 1.37 kg compared to resistance training plus placebo over 4 to 20 weeks [16]. Effect size was consistent across sexes and age groups. Dose: 3 to 5 g per day without a loading phase is equally effective to loading over 4 weeks.

Time-Restricted Eating

A 2020 RCT in Cell Metabolism (N=116, 12 weeks) comparing 16:8 time-restricted eating to unrestricted eating in adults with obesity found that the time-restricted group lost more weight (1.17% more) but also lost significantly more lean mass. The lean mass loss was attenuated when protein intake was matched [17]. Time-restricted eating without protein attention is a lean mass risk.

High-Intensity Interval Training (HIIT) vs. Steady-State Cardio

A 2012 meta-analysis in the Journal of Obesity (16 RCTs) found that HIIT protocols produced greater reductions in total absolute fat mass than continuous moderate-intensity exercise when total training time was equated [18]. HIIT did not produce greater lean mass changes. For fat loss on DEXA, HIIT is time-efficient but not superior if the weekly caloric expenditure from cardio is identical.

Testosterone Therapy in Men with Hypogonadism

In men with documented hypogonadism (total testosterone <300 ng/dL by LC-MS/MS), testosterone replacement therapy (TRT) produces measurable DEXA changes. The Testosterone Trials (TTrials, N=790, 12 months) found that testosterone gel 1% applied daily increased lean mass by a mean of 2.95 kg and reduced fat mass by 2.01 kg compared to placebo, with the changes detectable on DEXA at 6 months [19]. TRT is not a fat-loss drug in eugonadal men. The effect is specific to hypogonadal individuals.

Hormone Therapy in Postmenopausal Women

Postmenopausal estrogen decline accelerates visceral fat deposition and lean mass loss. The Women's Health Initiative (WHI) body composition substudy found that women on continuous combined estrogen-progestogen therapy had 1.1 kg less fat mass gain and 0.6 kg more lean mass retention over 3 years compared to placebo, with the VAT difference being the most pronounced regional change [20]. The decision to initiate hormone therapy involves a full risk-benefit analysis and is not indicated solely for body composition, but DEXA monitoring is appropriate for women on HRT.

How to Get the Most Accurate DEXA Results

Measurement error undermines your ability to detect real change. Standard pre-scan protocol reduces noise:

• Fast for at least 4 hours before the scan (water is fine).
• Avoid vigorous exercise in the 24 hours before scanning, as post-exercise fluid shifts can add 0.5 to 1 kg of apparent lean mass.
• Schedule the scan at the same time of day each visit, ideally morning.
• Use the same machine at the same facility. DEXA machines from different manufacturers (Hologic vs. GE Lunar) use different algorithms and are not directly comparable.
• Avoid the day before or day of menstruation if tracking lean mass precisely in women, as fluid retention can add 1 to 2 kg to apparent lean mass.
• Wear the same style of clothing (no metal, no thick fabric).

The International Society for Clinical Densitometry (ISCD) recommends that clinicians use the LSC to determine whether a measured change between scans is real or within measurement noise. For most modern DEXA systems, a change must exceed 2.0 to 2.5% in body fat and 0.8 to 1.2 kg in lean mass to be considered statistically meaningful [21].

Building a 16-Week DEXA Improvement Protocol

A structured 16-week block gives most adults enough time to produce a DEXA-detectable improvement. Below is the framework by goal.

Goal: Reduce Body Fat Percentage

• Caloric deficit of 400 to 600 kcal per day from baseline TDEE (measured by validated intake tracking for 7 days, not estimated).
• Protein: 1.8 to 2.0 g/kg target body weight per day, minimum.
• Resistance training: 3 times per week, compound movements (squat, hip hinge, press, row), progressive load increase every 1 to 2 weeks.
• Cardio: 150 to 200 minutes of moderate-intensity cardio per week OR 75 minutes of HIIT. Both produce similar DEXA fat loss at matched caloric output.
• Retest DEXA at week 16. Expected change based on trial data: 2 to 4% reduction in body fat percentage, 0.5 to 1.5 kg lean mass retained or slightly gained.

Goal: Increase Lean Mass

• Caloric surplus of 200 to 300 kcal per day above TDEE, or maintenance calories if body recomposition is the goal.
• Protein: 1.6 to 2.2 g/kg body weight per day.
• Resistance training: 4 sessions per week, 12 to 20 working sets per muscle group per week, 67 to 85% of 1RM.
• Creatine monohydrate: 5 g per day, taken consistently.
• Retest DEXA at week 16. Expected change: 1.5 to 3.0 kg lean mass gain in trained individuals, up to 4 to 6 kg in untrained individuals.